Exited portfolio companies

ActivX Biosciences, Inc.

ActivX Biosciences, Inc.

ActivX Biosciences, Inc. was acquired by Kyorin Pharmaceutical Co., Ltd. in 2004.


 

Arakis Ltd.

Arakis Ltd.

Arakis Ltd. was acquired by Sosei Co. Ltd. in 2005.


 

Arpida Ltd.

Arpida Ltd.

Arpida Ltd. (ARPN, SWX) is focused on the discovery and development of novel products for the treatment of microbial infections.


 

BioImage A/S

BioImage A/S

BioImage A/S outlicensed its lead compound to TopoTarget A/S in 2005, and sold its discovery business to Fisher Biosciences in 2006.


 

Cabrellis Pharmaceuticals Corp.

Cabrellis Pharmaceuticals Corp.

Cabrellis Pharmaceuticals Corp. was acquired by Pharmion Corporation in 2006.


 

Combio A/S

Combio A/S

CombioA/S was acquired by Arpida Ltd. in 2004.


 

Conforma Therapeutics Corp.

Conforma Therapeutics Corp.

Conforma Therapeutics Corp. was acquired by Biogen Idec in 2006.


 

Corus Pharma, Inc.

Corus Pharma, Inc.

Corus Pharma, Inc. was acquired by Gilead Sciences, Inc. in 2006.


 

Gloucester Pharmaceuticals

Gloucester Pharmaceuticals

Gloucester Pharmaceuticals was acquired by Celgene Corporation (NASDAQ, CELG) in 2010


 

InSound Medical, Inc.

InSound Medical, Inc.

InSound Medical, Inc. was acquired by Sonova Holding AG in 2010.


 

NatImmune A/S

NatImmune A/S

NatImmune A/S was acquired by Azanta A/S in 2009.


 

Neurodan A/S

Neurodan A/S

Neurodan A/S was acquired by Otto Bock GmbH Austria in 2005.


 

Novexel S.A.

Novexel S.A.

Novexel S.A. was acquired by AstraZeneca in 2010.


 

Panacos Pharmaceuticals, Inc.

Panacos Pharmaceuticals, Inc.

Panacos Pharmaceuticals, Inc. develops small molecule drugs against infectious disease.


 

PreciSense A/S

PreciSense A/S

PreciSense A/S sold its glucose monitoring assets to Medtronic Inc. in 2009.


 

Protein Forest, Inc.

Protein Forest, Inc.

Protein Forest, Inc. was acquired by Cell Bioscience, Inc. in 2009.


 

Salmedix, Inc.

Salmedix, Inc.

Salmedix, Inc. was acquired by Cephalon, Inc. in 2005.


 

Sapphire Therapeutics, Inc.

Sapphire Therapeutics, Inc.

Sapphire Therapeutics, Inc. was acquired by Helsinn S.A. in 2009.


 

Sosei Co. Ltd.

Sosei Co. Ltd.

Sosei Co. Ltd. acquired Arakis Ltd. in 2005.


 

Thiakis Ltd.

Thiakis Ltd.

Thiakis, Ltd. was acquired by Wyeth Pharmaceuticals, Inc. in 2008.


 

© Novo A/S 2009